Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension - Contacts and Locations

Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension

This study is currently recruiting participants.

Study NCT00454207. Last updated on December 2, 2008. Information provided by Pfizer

Please refer to this study by its ClinicalTrials.gov identifier: NCT00454207

Contacts


Contact: Pfizer CT.gov Call Center	1-800-718-1021

Locations


Japan
	Pfizer Investigational Site	Recruiting
	Tokyo, Japan

Japan, Chiba
	Pfizer Investigational Site	Completed
	Chiba-shi, Chiba, Japan

Japan, Ishikawa
	Pfizer Investigational Site	Completed
	Kanazawa, Ishikawa, Japan

Japan, Mie
	Pfizer Investigational Site	Completed
	Tsu-shi, Mie, Japan

Japan, Okayama
	Pfizer Investigational Site	Completed
	Okayama City, Okayama, Japan

Japan, Shizuoka
	Pfizer Investigational Site	Completed
	Hamamatsu-shi, Shizuoka, Japan

Japan, Tokyo
	Pfizer Investigational Site	Completed
	Shinjuku-ku, Tokyo, Japan
	Pfizer Investigational Site	Completed
	Bunkyo-ku, Tokyo, Japan

Sponsors and Collaborators

Pfizer

Investigators


Study Director:	Pfizer CT.gov Call Center	Pfizer